When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
A Phase IV Study of Antiretroviral Therapy for HIV Infected Adults Presenting With Acute Opportunistic Infections: Immediate Versus Deferred Initiation of Antiretroviral Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
A PHASE4 clinical study on AIDS-Related Opportunistic Infections and HIV Infections, this trial is completed. The trial is conducted by National Institute of Allergy and Infectious Diseases (NIAID) and has accumulated 6 data snapshots since 2003. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Mar 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Atlanta, United States, Baltimore, United States, Boston, United States, Chapel Hill, United States, Chicago, United States, Cincinnati, United States, Cleveland, United States, Columbus, United States, Dallas, United States, Denver, United States and 19 more location s